The Melanoma Research Alliance (MRA) is pleased to welcome Jeffrey Rowbottom, managing director of Kohlberg Kravis Roberts & Co. to MRA’s Board of Directors. Rowbottom joined KKR in 2009 and is a member of KKR Capital Markets, serving as co-head for North America.
